Prognostic Significance of CEA in Colorectal Cancer: A Statistical Study. Clinical evaluation of carcino-embryonic antigen, V
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Bibliographic citation
-
In: Clinical Chemistry and Laboratory Medicine, Band 19, Ausgabe 11, Seite 1117-1124, 2009
- Event
-
Veröffentlichung
- (where)
-
Berlin
- (who)
-
Humboldt-Universität zu Berlin
- (when)
-
1981
- Creator
-
PERSIJN, J.-P.
Hart, A. A. M.
- DOI
-
10.18452/9555
- URN
-
urn:nbn:de:kobv:11-100113865
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- PERSIJN, J.-P.
- Hart, A. A. M.
- Humboldt-Universität zu Berlin
Time of origin
- 1981
Other Objects (12)
Carcino-Embryonic Antigen Activity in Urine of Patients with Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, II.
Carcino-Embryonic Antigens, Oestrogen Receptors and Androgen Receptors in Human Breast Tumours. Clinical evaluation of carcino-embryonic antigen, IV
Clinical Significance of Urinary Carcino-Embryonic Antigen Estimations During the Follow-Up of Patients with Bladder Carcinoma or Previous Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, III.
Carcinoembryonic antigens
Biochemical and Immunochemical Aspects of Carcinoembryonic Antigen (CEA) and CEA Related Antigens: Current Status and Future Perspectives
Binding of Carcinoembryonic Antigen (CEA) to an Anti-CEA Immunosorbent in the Presence of Detergents
Structure, evolution and regulation of expression of the carcinoembryonic antigen (CEA) gene family
Carcinoembryonic Antigen (CEA), Nonspecific Crossreacting Antigen (NCA) und Tissue Polypeptide Antigen (TPA) bei kolorektalen Karzinomen : e. immunhistochem. Unters.
Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
Study of the immunological and biochemical relationship of carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA)
Simultanbestimmung der tumorassoziierten Antigene TPA (Tissue Polypeptid Antigen) und CEA (Carcinoembryonic Antigen) in Urin und Plasma bei Patienten mit urothelialem Harnblasenkarzinom
Carcino-Embryonic Antigen Activity in Urine of Patients with Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, II.
Carcino-Embryonic Antigens, Oestrogen Receptors and Androgen Receptors in Human Breast Tumours. Clinical evaluation of carcino-embryonic antigen, IV
Clinical Significance of Urinary Carcino-Embryonic Antigen Estimations During the Follow-Up of Patients with Bladder Carcinoma or Previous Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, III.
Carcinoembryonic antigens
Biochemical and Immunochemical Aspects of Carcinoembryonic Antigen (CEA) and CEA Related Antigens: Current Status and Future Perspectives
Binding of Carcinoembryonic Antigen (CEA) to an Anti-CEA Immunosorbent in the Presence of Detergents
Structure, evolution and regulation of expression of the carcinoembryonic antigen (CEA) gene family
Carcinoembryonic Antigen (CEA), Nonspecific Crossreacting Antigen (NCA) und Tissue Polypeptide Antigen (TPA) bei kolorektalen Karzinomen : e. immunhistochem. Unters.
Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
Study of the immunological and biochemical relationship of carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA)
Simultanbestimmung der tumorassoziierten Antigene TPA (Tissue Polypeptid Antigen) und CEA (Carcinoembryonic Antigen) in Urin und Plasma bei Patienten mit urothelialem Harnblasenkarzinom
Carcino-Embryonic Antigen Activity in Urine of Patients with Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, II.
Carcino-Embryonic Antigens, Oestrogen Receptors and Androgen Receptors in Human Breast Tumours. Clinical evaluation of carcino-embryonic antigen, IV
Clinical Significance of Urinary Carcino-Embryonic Antigen Estimations During the Follow-Up of Patients with Bladder Carcinoma or Previous Bladder Carcinoma. Clinical Evaluation of Carcino-Embryonic Antigen, III.
Carcinoembryonic antigens
Biochemical and Immunochemical Aspects of Carcinoembryonic Antigen (CEA) and CEA Related Antigens: Current Status and Future Perspectives
Binding of Carcinoembryonic Antigen (CEA) to an Anti-CEA Immunosorbent in the Presence of Detergents
Structure, evolution and regulation of expression of the carcinoembryonic antigen (CEA) gene family
Carcinoembryonic Antigen (CEA), Nonspecific Crossreacting Antigen (NCA) und Tissue Polypeptide Antigen (TPA) bei kolorektalen Karzinomen : e. immunhistochem. Unters.
Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer
Carcinoembryonic antigen (CEA) level, CEA ratio, and treatment outcome of rectal cancer patients receiving pre-operative chemoradiation and surgery
Study of the immunological and biochemical relationship of carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA)